MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 22, 2004; DOI: 10.1124/mol.104.008698


0026-895X/05/6704-1026-1033$20.00
Mol Pharmacol 67:1026-1033, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.008698v1
67/4/1026    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreau, C.
Right arrow Articles by Vivaudou, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreau, C.
Right arrow Articles by Vivaudou, M.
Original Article

The Size of a Single Residue of the Sulfonylurea Receptor Dictates the Effectiveness of KATP Channel Openers

Christophe Moreau1, Fabienne Gally, Heélène Jacquet-Bouix2, and Michel Vivaudou

Biophysique Moléculaire and Cellulaire, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5090, Commissariat à l'Energie Atomique/Département de Rêponse et Dynamique Cellulaire, Grenoble, France

Abstract

KATP channel openers are a diverse group of molecules able to activate ATP-sensitive K+ channels in a tissue-dependent manner by binding to the channel regulatory subunit, the sulfonylurea receptor (SUR), an ATP-binding cassette protein. Residues crucial to this action were previously identified in the last transmembrane helix of SUR, transmembrane helix 17. This study examined the residue at the most important position, 1253 in the muscle isoform SUR2A and the matching 1290 in the pancreatic/neuronal isoform SUR1 (rat numbering). At this position in either isoform, a threonine enables action of openers, whereas a methionine prohibits it. Using single-point mutagenesis, we have examined the physicochemical basis of this phenomenon and discovered that it relied uniquely on side chain volume and not on shape, polarity, or hydrogen-bonding capacity of the residue. Moreover, the aromatic nature of neighboring residues conserved in SUR1 and SUR2A was found necessary for SUR2A to sustain the wild-type levels of channel activation by the openers tested, the cromakalim analog SR47063 [4-(2-cyanimino-1,2-dihydro-1-pyridyl)-2,2-dimethyl-6-nitrochromene] and the pinacidil analog P1075 [N-cyano-N'-(1,1-dimethylpropyl)-N'-3-pyridylguanidine]. These observations suggest that these residues can interact with openers via nonspecific stacking interactions provided that the adjacent 1253/1290 residue does not obstruct access. The smaller Thr1253 of SUR2A would permit activation, whereas the bulky Met1290 of SUR1 would not. This hypothesis is discussed in the context of a simple molecular model of transmembrane helix 17.


Received October 26, 2004; accepted December 22, 2004

Address correspondence to: Dr. Michel Vivaudou, CEA/DRDC-BMC, 17 rue des Martyrs, 38054, Grenoble, France. E-mail: vivaudou{at}cea.fr




This article has been cited by other articles:


Home page
J. Physiol.Home page
J. P. Dupuis, J. Revilloud, C. J. Moreau, and M. Vivaudou
Three C-terminal residues from the sulphonylurea receptor contribute to the functional coupling between the KATP channel subunits SUR2A and Kir6.2
J. Physiol., July 1, 2008; 586(13): 3075 - 3085.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Hosy, R. Derand, J. Revilloud, and M. Vivaudou
Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123
J. Physiol., July 1, 2007; 582(1): 27 - 39.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics